Monthly Archives: November 2022

//November

PQS: Assessment framework now available

Community pharmacy contractors can now access the assessment framework on PharmOutcomes for the 2022/23 Pharmacy Quality Scheme (PQS). This is available free of charge to all contractors. The assessment framework allows contractors and their teams to track their progress with achieving the gateway and quality criteria/domains of the PQS. Once a contractor has logged into PharmOutcomes, [...]

The post PQS: Assessment framework now available appeared first on PSNC Website.

By |November 22nd, 2022|Lexpos News|Comments Off on PQS: Assessment framework now available

November 2022 Price Concessions 2nd Update

The Department of Health and Social Care (DHSC) has today (22/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Alendronic acid 70mg tablets 4 £5.36 Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amorolfine 5% medicated nail lacquer 5 £7.34 Aripiprazole [...]

The post November 2022 Price Concessions 2nd Update appeared first on PSNC Website.

By |November 22nd, 2022|Lexpos News|Comments Off on November 2022 Price Concessions 2nd Update

Help improve the Electronic Prescription Service

NHS Digital is asking community pharmacy team members to share their experience of using the Electronic Prescription Service (EPS) by volunteering to take part with a short EPS interview. Such user feedback is essential to informing the future development of the system ahead of the planned launch of the next generation of EPS. PSNC and [...]

The post Help improve the Electronic Prescription Service appeared first on PSNC Website.

By |November 21st, 2022|Lexpos News|Comments Off on Help improve the Electronic Prescription Service

MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited)

Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) Drug alert number: EL (22)A/48 Date issued: 21 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Hyoscine Butylbromide 20 mg film-coated tablets, PL 20117/0349 Batch Number Expiry Date Pack [...]

The post MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) appeared first on PSNC Website.

By |November 21st, 2022|Lexpos News|Comments Off on MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited)

November 2022 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (18/11/2022) granted the following initial list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.69 Amoxicillin 250mg/5ml oral suspension sugar free 100 £2.69 Benzydamine 0.15% mouthwash sugar free 300 £4.65 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol [...]

The post November 2022 Price Concessions 1st Update appeared first on PSNC Website.

By |November 18th, 2022|Lexpos News|Comments Off on November 2022 Price Concessions 1st Update